Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.042M
March 31, 2026 -0.038M
December 31, 2025 -0.553M
September 30, 2025 -0.653M
June 30, 2025 -0.685M
March 31, 2025 -0.069M
December 31, 2024 -0.151M
September 30, 2024 -0.617M
June 30, 2024 -0.358M
March 31, 2024 -0.028M
December 31, 2023 -0.043M
September 30, 2023 -0.408M
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 -0.423M
June 30, 2022 -0.128M
March 31, 2022 -0.111M
December 31, 2021 -0.019M
September 30, 2021 -0.153M
June 30, 2021 -0.005M
March 31, 2021 -0.676M
December 31, 2020 -0.105M
September 30, 2020 -0.058M
June 30, 2020 -0.153M
Date Value
March 31, 2020 -0.005M
December 31, 2019 -0.015M
September 30, 2019 0.00
June 30, 2019 -0.375M
March 31, 2019 -1.01M
December 31, 2018 -0.635M
September 30, 2018 -1.185M
June 30, 2018 -29.72M
March 31, 2018 -0.36M
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.13M
March 31, 2017 -0.17M
December 31, 2016 -0.102M
September 30, 2016 0.041M
June 30, 2016 -1.516M
March 31, 2016 -7.662M
December 31, 2015 -0.544M
September 30, 2015 -5.545M
June 30, 2015 -90.64M
March 31, 2015 -3.065M
December 31, 2014 -2.136M
September 30, 2014 -1.301M
June 30, 2014 -1.683M
March 31, 2014 -5.977M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Liquidia Corp. -1.443M
Eli Lilly & Co. 1.601B
Indivior Pharmaceuticals, Inc. 175.35M
Viatris, Inc. 149.30M
Pfizer Inc. 0.00